Reg Joseph

Vice President, Translational, Product & Technology Innovation, Alberta Innovates Health Solutions

Reg has 15 years’ experience in the biotechnology and high technology sectors and has worked with large publically traded firms, start-ups, and the investment banking industry. His prior experience includes serving as an equity research analyst with Boston-based Leerink Swann & Co., where he covered the life science tools sector. He also spent four years at US-based Invitrogen Corp (now Thermo Fisher) in a variety of roles including licensing, product development, acquisitions and integration. Reg has also served in a variety of C-level and board positions with local medical technology-based start-ups.

Reg currently serves on the Board of BioTalent Canada and is a mentor for the AllerGen NCE commercialization program. He also sits on BioAlberta’s policy committee and serves on the board of the Seniors Association of Greater Edmonton (SAGE).